Cointime

Aprecia Pharmaceuticals

company

About

Aprecia Pharmaceuticals develops precision drug delivery systems and products.

  • 51 - 100

Highlights

Total Funding Amount
$30M
Funding Rounds
1
Investors
1
Investments
1

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
$30M
Industries
Biopharma,Biotechnology,Pharmaceutical
Founded date
Jan 1, 2003
Number Of Employee
51 - 100
Operating Status
Active

Aprecia Pharmaceuticals Company develops and manufactures precision drug delivery systems and products. Its products include CustomRelease that provides various time release profiles; ZipDose, a orally dispersing wafers pairing a high dose ceiling with times, taste-masking options, and IR/ER combinations; and NanoDose that is suited for products requiring submilligram doses. The company also offers ImplantaDose, which is suited for post surgical management of infections and associated pain, and sequential release of biomimetic proteins and peptides.

Aprecia Pharmaceuticals Company was incorproated in 2003 and is based in Langhorne, Pennsylvania.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$30M
Aprecia Pharmaceuticals has raised a total of $30M in funding over 2 rounds. Their latest funding was raised on Jul 5, 2016 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 5, 2016 Debt Financing $30M 1 Hercules Capital — Detail

Investments

Number of Investments
Number of Lead Investments
1
0
Aprecia Pharmaceuticals has made 1 investments. Their most recent investment was on Sep 22, 2020, when FCFL raised 0.
Date Company Name
Round Money Raised Industry Lead Investor
Sep 22, 2020 FCFL
Series Unknown — Blockchain —

Investors

Number of Lead Investors
Number of Investors
1
1
Aprecia Pharmaceuticals is funded by 1 investors. Hercules Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Hercules Capital Yes Debt Financing
Cointime
İçerikler
Şirket.